King Robert
Chief Development Officer at ALEC; SVP of Prod. Dev/Supply Chain at SCICLONE PHARMACEUTICALS INC
- Sold, on record
- $3.8M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Sep 2, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ALECAlector, Inc.Chief Development Officer
- SCICLONE PHARMACEUTICALS INCSVP of Prod. Dev/Supply Chain
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ALEC120,890 shares
- SCICLONE PHARMACEUTICALS INC48,667 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ALECPlan not statedJan 22 2020
Sold 15,000 shares at $22.01 ($330k)
King Robert, Chief Development Officer
Sold 2.9% of holdings ($11.5M position)507,317 shares leftFiling
- 2 Form 4 sale ALECPlan not statedFeb 14 +23 days
Sold 15,000 shares at $29.56 ($443k)
King Robert, Chief Development Officer
Sold 3% of holdings ($15M position)492,317 shares left2x usual sizeFiling
- 3 Form 4 sale ALECPlan not statedMay 15 +91 days
Sold 15,000 shares at $27.00 ($405k)
King Robert, Chief Development Officer
Sold 3% of holdings ($13.3M position)477,317 shares left1.3x usual sizeFiling
- 4 Form 4 sale ALECUnusualJul 2 +413 days
Sold 60,000 shares at $31.14 ($1.9M)
King Robert, Chief Development Officer
Sold 10.3% of holdings ($18.1M position)522,317 shares left4x usual sizeFiling
- 5 Form 4 sale ALECPlan not statedDec 1 +152 days
Sold 250 shares at $20.09 ($5k)
King Robert, Chief Development Officer
Sold 0% of holdings ($10.6M position)528,691 shares left0x usual sizeFiling
- 6 Form 4 sale ALECPlan not statedMar 1 +90 days
Sold 287 shares at $15.57 ($4k)
King Robert, Chief Development Officer
Sold 0.1% of holdings ($8.2M position)528,404 shares left0x usual sizeFiling
- 7 Form 4 sale ALECPlan not statedJun 2 +93 days
Sold 177 shares at $8.71 ($2k)
King Robert, Chief Development Officer
Sold 0% of holdings ($4.6M position)529,471 shares left0.6x usual sizeFiling
- 8 Form 4 sale ALECPlan not statedSep 2 +92 days
Sold 176 shares at $10.62 ($2k)
King Robert, Chief Development Officer
Sold 0% of holdings ($5.6M position)529,295 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | ALEC | Chief Development Officer | Form 4 sale | 176 | $2k | 0.0% | Plan not stated | SEC |
| Jun 2, 2022 | ALEC | Chief Development Officer | Form 4 sale | 177 | $2k | 0.0% | Plan not stated | SEC |
| Mar 1, 2022 | ALEC | Chief Development Officer | Form 4 sale | 287 | $4k | 0.1% | Plan not stated | SEC |
| Dec 1, 2021 | ALEC | Chief Development Officer | Form 4 sale | 250 | $5k | 0.0% | Plan not stated | SEC |
| Jul 2, 2021 | ALEC | Chief Development Officer | Form 4 sale | 60,000 | $1.9M | 10.3% | Unusual | SEC |
| May 15, 2020 | ALEC | Chief Development Officer | Form 4 sale | 15,000 | $405k | 3.0% | Plan not stated | SEC |
| Feb 14, 2020 | ALEC | Chief Development Officer | Form 4 sale | 15,000 | $443k | 3.0% | Plan not stated | SEC |
| Jan 22, 2020 | ALEC | Chief Development Officer | Form 4 sale | 15,000 | $330k | 2.9% | Plan not stated | SEC |
| Nov 15, 2019 | ALEC | Chief Development Officer | Form 4 sale | 7,500 | $119k | 1.4% | Plan not stated | SEC |
| Aug 19, 2019 | ALEC | Chief Development Officer | Form 4 sale | 7,500 | $113k | 1.4% | Plan not stated | SEC |
| Aug 12, 2016 | SCICLONE PHARMACEUTICALS INC | SVP of Prod. Dev/Supply Chain | Form 4 sale | 48,667 | $507k | 74.3% | Unusual | SEC |